Status:

COMPLETED

Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients

Lead Sponsor:

Beni-Suef University

Conditions:

Diabetic Neuropathies

Eligibility:

All Genders

20-100 years

Phase:

NA

Brief Summary

Evaluation of the influence of oral administration of carnosine in combination with vitamin B Complex in preventing the progression of diabetic neuropathy in type 2 diabetes patients.

Detailed Description

Diabetic peripheral neuropathy (DPN) is considered the most common chronic complication of diabetes mellitus, with an incidence rate of about 50%. DPN is a group of clinical syndromes that affects si...

Eligibility Criteria

Inclusion

  • Type 2 diabetes Patients as per ADA criteria.
  • Patients were showing clinical signs of Diabetic neuropathy verified by a neurologist and confirmed by a score ≥7 on the MNSI questionnaire (Michigan Neuropathy Screening Instrument), with abnormal nerve conduction measurement.
  • Patients on a regular visit to the clinic.

Exclusion

  • Patients with neuropathy of non-diabetic origin were excluded.
  • Patients with a BMI of 40 kg/m2 or more and those pregnant or breastfeeding were also excluded

Key Trial Info

Start Date :

January 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 28 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05422352

Start Date

January 14 2021

End Date

March 28 2022

Last Update

June 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beni Suef University faculty of pharmacy

Banī Suwayf, Beni Suweif Governorate, Egypt, 62511